These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 17449877)

  • 21. Usefulness of QRS duration to predict response to cardiac resynchronization therapy in patients with end-stage heart failure.
    Mollema SA; Bleeker GB; van der Wall EE; Schalij MJ; Bax JJ
    Am J Cardiol; 2007 Dec; 100(11):1665-70. PubMed ID: 18036366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation of an echocardiographic multiparametric strategy to increase responders patients after cardiac resynchronization: a multicentre study.
    Lafitte S; Reant P; Zaroui A; Donal E; Mignot A; Bougted H; Belghiti H; Bordachar P; Deplagne A; Chabaneix J; Franceschi F; Deharo JC; Dos Santos P; Clementy J; Roudaut R; Leclercq C; Habib G
    Eur Heart J; 2009 Dec; 30(23):2880-7. PubMed ID: 19136487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early and late effects of cardiac resynchronization therapy on exercise-induced mitral regurgitation: relationship with left ventricular dyssynchrony, remodelling and cardiopulmonary performance.
    Madaric J; Vanderheyden M; Van Laethem C; Verhamme K; Feys A; Goethals M; Verstreken S; Geelen P; Penicka M; De Bruyne B; Bartunek J
    Eur Heart J; 2007 Sep; 28(17):2134-41. PubMed ID: 17504802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimization of the interventricular delay in cardiac resynchronization therapy using the QRS width.
    Tamborero D; Mont L; Sitges M; Silva E; Berruezo A; Vidal B; Delgado V; Tolosana JM; Godoy M; Castel A; Brugada J
    Am J Cardiol; 2009 Nov; 104(10):1407-12. PubMed ID: 19892059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paced left ventricular QRS width and ECG parameters predict outcomes after cardiac resynchronization therapy: PROSPECT-ECG substudy.
    Hsing JM; Selzman KA; Leclercq C; Pires LA; McLaughlin MG; McRae SE; Peterson BJ; Zimetbaum PJ
    Circ Arrhythm Electrophysiol; 2011 Dec; 4(6):851-7. PubMed ID: 21956038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiac resynchronization therapy in patients with systolic left ventricular dysfunction and symptoms of mild heart failure secondary to ischemic or nonischemic cardiomyopathy.
    Bleeker GB; Schalij MJ; Holman ER; Steendijk P; van der Wall EE; Bax JJ
    Am J Cardiol; 2006 Jul; 98(2):230-5. PubMed ID: 16828599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ventricular asynchrony predicts a better outcome in patients with chronic heart failure receiving cardiac resynchronization therapy.
    Pitzalis MV; Iacoviello M; Romito R; Guida P; De Tommasi E; Luzzi G; Anaclerio M; Forleo C; Rizzon P
    J Am Coll Cardiol; 2005 Jan; 45(1):65-9. PubMed ID: 15629375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical outcomes after cardiac resynchronization therapy: importance of left ventricular diastolic function and origin of heart failure.
    Waggoner AD; Rovner A; de las Fuentes L; Faddis MN; Gleva MJ; Sawhney N; Dávila-Román VG
    J Am Soc Echocardiogr; 2006 Mar; 19(3):307-13. PubMed ID: 16500494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure.
    St John Sutton MG; Plappert T; Abraham WT; Smith AL; DeLurgio DB; Leon AR; Loh E; Kocovic DZ; Fisher WG; Ellestad M; Messenger J; Kruger K; Hilpisch KE; Hill MR;
    Circulation; 2003 Apr; 107(15):1985-90. PubMed ID: 12668512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diastolic filling pattern and left ventricular diameter predict response and prognosis after cardiac resynchronisation therapy.
    Gradaus R; Stuckenborg V; Löher A; Köbe J; Reinke F; Gunia S; Vahlhaus C; Breithardt G; Bruch C
    Heart; 2008 Aug; 94(8):1026-31. PubMed ID: 17984216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy.
    Bax JJ; Bleeker GB; Marwick TH; Molhoek SG; Boersma E; Steendijk P; van der Wall EE; Schalij MJ
    J Am Coll Cardiol; 2004 Nov; 44(9):1834-40. PubMed ID: 15519016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.
    Daubert C; Gold MR; Abraham WT; Ghio S; Hassager C; Goode G; Szili-Török T; Linde C;
    J Am Coll Cardiol; 2009 Nov; 54(20):1837-46. PubMed ID: 19800193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of the longest intrapatient left ventricular electrical delay may predict acute hemodynamic improvement in patients after cardiac resynchronization therapy.
    Zanon F; Baracca E; Pastore G; Fraccaro C; Roncon L; Aggio S; Noventa F; Mazza A; Prinzen F
    Circ Arrhythm Electrophysiol; 2014 Jun; 7(3):377-83. PubMed ID: 24668162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial.
    Ruwald MH; Solomon SD; Foster E; Kutyifa V; Ruwald AC; Sherazi S; McNitt S; Jons C; Moss AJ; Zareba W
    Circulation; 2014 Dec; 130(25):2278-86. PubMed ID: 25301831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Response to preventive cardiac resynchronization therapy in patients with ischaemic and nonischaemic cardiomyopathy in MADIT-CRT.
    Barsheshet A; Goldenberg I; Moss AJ; Eldar M; Huang DT; McNitt S; Klein HU; Hall WJ; Brown MW; Goldberger JJ; Goldstein RE; Schuger C; Zareba W; Daubert JP
    Eur Heart J; 2011 Jul; 32(13):1622-30. PubMed ID: 21075774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of baseline PR interval on cardiac resynchronization therapy outcomes in patients with narrow QRS complexes: an analysis of the ReThinQ Trial.
    Joshi NP; Stopper MM; Li J; Beshai JF; Pavri BB
    J Interv Card Electrophysiol; 2015 Aug; 43(2):145-9. PubMed ID: 25921348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of response to cardiac resynchronization therapy--importance of left ventricular dyssynchrony.
    Santos JF; Parreira L; Madeira J; Seixo F; Mendes L; Lopes C; Venâncio J; Lourenço J; Caetano F; Inês L; Mendes M
    Rev Port Cardiol; 2006 Jun; 25(6):569-81. PubMed ID: 17019976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Scar burden by myocardial perfusion imaging predicts echocardiographic response to cardiac resynchronization therapy in ischemic cardiomyopathy.
    Adelstein EC; Saba S
    Am Heart J; 2007 Jan; 153(1):105-12. PubMed ID: 17174647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study.
    Hsu JC; Solomon SD; Bourgoun M; McNitt S; Goldenberg I; Klein H; Moss AJ; Foster E;
    J Am Coll Cardiol; 2012 Jun; 59(25):2366-73. PubMed ID: 22698490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiac resynchronization therapy in patients with intrinsic and right ventricular pacing-induced left bundle branch block pattern.
    Shen X; Aronow WS; Holmberg MJ; Li H; Nair CK; Korlakunta H; Esterbrooks DJ
    Am J Ther; 2009; 16(6):e44-50. PubMed ID: 19940605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.